A detailed history of Umb Bank, N.A. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 80 shares of BLFS stock, worth $2,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 47 70.21%
Holding current value
$2,197
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$19.19 - $26.52 $633 - $875
33 Added 70.21%
80 $2,000
Q2 2024

Jul 29, 2024

BUY
$15.14 - $22.99 $439 - $666
29 Added 161.11%
47 $1,000
Q1 2024

Apr 26, 2024

BUY
$15.35 - $18.82 $276 - $338
18 New
18 $0
Q2 2022

Jul 20, 2022

SELL
$10.54 - $24.2 $664 - $1,524
-63 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$20.81 - $37.29 $1,311 - $2,349
63 New
63 $1,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.17B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.